In a recent study conducted by researchers at Dalhousie University in Canada, cannabis and its compounds have emerged as potential allies in the fight against COVID-19.
Published in the Journal of Clinical Medicine, the study explored the preventive and therapeutic capabilities of cannabinoids in both the early and post-infection stages of the disease.
The research revealed that cannabinoids exhibit the ability to impede viral entry, reduce oxidative stress and alleviate the cytokine storm associated with early COVID-19 infections, which suggested a potential role for cannabis in limiting the ‘susceptibility and severity’ of the virus.
Published in the Journal of Clinical Medicine, the study explored the preventive and therapeutic capabilities of cannabinoids in both the early and post-infection stages of the disease.
The research revealed that cannabinoids exhibit the ability to impede viral entry, reduce oxidative stress and alleviate the cytokine storm associated with early COVID-19 infections, which suggested a potential role for cannabis in limiting the ‘susceptibility and severity’ of the virus.